Bioavailability of Aciclovir after Oral Administration of Aciclovir and Its Prodrug Valaciclovir to Patients with Leukopenia after Chemotherapy

The median bioavailabilities of aciclovir after administration of aciclovir and its prodrug valaciclovir were 21.5 and 70.1%, respectively, in 12 patients with malignant hematological diseases with leukopenia after chemotherapy. The interindividual variations of the bioavailability were 48.5 and 21....

תיאור מלא

מידע ביבליוגרפי

הוצא לאור ב:	Antimicrob Agents Chemother
Principais autores:	Steingrimsdottir, Hlif, Gruber, Astrid, Palm, Carina, Grimfors, Gunnar, Kalin, Mats, Eksborg, Staffan
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	American Society for Microbiology (ASM) 2000
נושאים:	Pharmacology
גישה מקוונת:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89657/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10602752/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.1.207-209.2000
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!